Better EV Stock to Buy Right Now: Nio vs. Rivian
Stock prices used were the market prices of July 11, 2025. The video was published on July 21, 2025.
Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue »
Should you invest $1,000 in Nio right now?
Before you buy stock in Nio, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Nio wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $652,133!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,056,790!*
Now, it's worth noting Stock Advisor's total average return is 1,048% — a market-crushing outperformance compared to 180% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor.
See the 10 stocks »
*Stock Advisor returns as of July 21, 2025
Rick Orford has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
42 minutes ago
- Globe and Mail
Automatic Data Processing to Report Q4 Earnings: What's in Store?
Automatic Data Processing, Inc. ADP is scheduled to release fourth-quarter fiscal 2025 results on July 30, before market open. ADP has a decent earnings surprise history, surpassing the Zacks Consensus Estimate in the trailing four quarters, with an average surprise of 3.5%. Automatic Data Processing, Inc. Price and EPS Surprise Automatic Data Processing, Inc. price-eps-surprise | Automatic Data Processing, Inc. Quote Automatic Data Processing's Q4 Expectations The Zacks Consensus Estimate for the top line is $5.1 billion, hinting at a 5.9% year-over-year increase. We expect gains across segments to have supported revenue growth. Our estimation for fourth-quarter fiscal 2025 revenues from Employer Service is $3.4 billion, suggesting growth of 5.7% from the year-ago quarter's actual. We expect business bookings to have fueled this segment's growth. We anticipate revenues of Professional Employer Organization ('PEO') services to be $1.6 billion, indicating 5.6% year-over-year growth. The factors likely to have driven this segment are higher wages and strong retention. Our estimate for Interest on Funds held for clients is $287.9 million, implying a 4% rise from the year-ago quarter's reported figure. Stronger average client funds balance growth is anticipated to have benefited this segment. Our estimate for Average Paid PEO Worksite Employees for the quarter is 762. Changes in Pay per control are anticipated to be 0.1% for the to-be-reported quarter. The consensus estimate for earnings per share is set at $2.22, indicating a 6.2% year-over-year increase. Strong top-line growth, along with disciplined cost control, is expected to have aided the bottom line. What Our Model Says About ADP Our proven model does not conclusively predict an earnings beat for Automatic Data Processing this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. But that is not the case here. You can uncover the best stocks before they are reported with our Earnings ESP Filter. ADP has an Earnings ESP of -0.53% and a Zacks Rank of 3 at present. You can see the complete list of today's Zacks #1 Rank stocks here. Stocks to Consider Here are a few stocks from the broader Computer And Technology sector, which, according to our model, have the right combination of elements to beat on earnings this season. Seagate Technology STX: The Zacks Consensus Estimate for the company's fiscal fourth-quarter 2025 revenues is pegged at $2.4 billion, indicating a year-over-year increase of 27.5%. For earnings, the consensus mark is pegged at $2.46 per share, suggesting a more than 100% surge from that reported in the year-ago quarter. The company beat the Zacks Consensus Estimate in the past four quarters, with an average surprise of 15.7%. STX currently has an Earnings ESP of +2.34% and a Zacks Rank #2. The company is scheduled to declare fourth-quarter fiscal 2025 results on July 29. Apple AAPL: The Zacks Consensus Estimate for the company's third-quarter fiscal 2025 revenues is pegged at $88.9 billion, suggesting year-over-year growth of 3.7%. For earnings, the consensus mark is pegged at $1.42 per share, implying a 1.43% rise from the year-ago quarter's actual. The company beat the Zacks Consensus Estimate in the past four quarters, with an average surprise of 4.7%. AAPL has an Earnings ESP of +3.52% and a Zacks Rank #3 at present. The company is scheduled to declare third-quarter fiscal 2025 results on July 31. #1 Semiconductor Stock to Buy (Not NVDA) The incredible demand for data is fueling the market's next digital gold rush. As data centers continue to be built and constantly upgraded, the companies that provide the hardware for these behemoths will become the NVIDIAs of tomorrow. One under-the-radar chipmaker is uniquely positioned to take advantage of the next growth stage of this market. It specializes in semiconductor products that titans like NVIDIA don't build. It's just beginning to enter the spotlight, which is exactly where you want to be. See This Stock Now for Free >> Apple Inc. (AAPL): Free Stock Analysis Report
Globe and Mail
42 minutes ago
- Globe and Mail
Rigetti Gains 44% in 1 Month: Is Investor Sentiment Starting to Shift?
Rigetti Computing RGTI has surged nearly 44% over the past month, buoyed by a significant technical milestone announced on July 16. The company achieved 99.5% median two-qubit gate fidelity on its new modular 36-qubit system, marking a two-times improvement over its prior best. The system, built from four tiled 9-qubit 'chiplets,' showcases Rigetti's proprietary modular architecture — a key step toward launching a 100+ qubit chiplet-based system by late 2025. The 36-qubit system is set to go live on Aug. 15, reinforcing Rigetti's positioning as a serious full-stack quantum hardware innovator. What makes Rigetti's approach stand out is its vertically integrated model, encompassing in-house chip fabrication, modular hardware, and cloud access via QCS (Quantum Cloud Services). Unlike peers that rely on third-party infrastructure, Rigetti builds its stack end-to-end, a setup that could enable faster iteration and tighter quality control. This integration also positions the company to better align hardware and software development cycles. While Rigetti's revenue base remains relatively small and concentrated in research and government contracts, its consistent technical progress and clear product roadmap are beginning to register with investors looking for long-term potential. Peers Updates By contrast, Arqit Quantum ARQQ stock has lost 3.2% over the same period. The company, initially focused on quantum encryption, has since expanded into broader cybersecurity offerings. It continues to pursue government and defense-related engagements, including collaborations with UK-based defense agencies. However, its evolving business model and shift away from pure-play quantum narratives have led to mixed investor sentiment, as the market assesses its long-term role and differentiation within the broader quantum and cybersecurity landscape. Quantum Computing Inc. QUBT is up approximately 1% over the past month. The company focuses on software-driven quantum and AI solutions, offering platforms like Qatalyst, which aims to simplify quantum optimization through a hardware-agnostic interface. It also recently introduced Dirac, a system designed to support entropy-based quantum processing without the need for cryogenic infrastructure. QUBT is targeting enterprise and cloud-based use cases as it works to expand its footprint in the emerging quantum software space. Rigetti's Price Performance, Valuation and Estimates Shares of RGTI have gained 4.6% in the year-to-date period compared with the industry 's growth of 17.9%. From a valuation standpoint, Rigetti trades at a price-to-book ratio of 22.36, above the industry average. RGTI carries a Value Score of F. The Zacks Consensus Estimate for Rigetti's 2025 earnings implies a significant 86.1% rise from the year-ago period. The company currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. #1 Semiconductor Stock to Buy (Not NVDA) The incredible demand for data is fueling the market's next digital gold rush. As data centers continue to be built and constantly upgraded, the companies that provide the hardware for these behemoths will become the NVIDIAs of tomorrow. One under-the-radar chipmaker is uniquely positioned to take advantage of the next growth stage of this market. It specializes in semiconductor products that titans like NVIDIA don't build. It's just beginning to enter the spotlight, which is exactly where you want to be. See This Stock Now for Free >> Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Quantum Computing Inc. (QUBT): Free Stock Analysis Report Arqit Quantum Inc. (ARQQ): Free Stock Analysis Report Rigetti Computing, Inc. (RGTI): Free Stock Analysis Report
Globe and Mail
an hour ago
- Globe and Mail
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RxSight
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against RxSight, Inc. ('RxSight' or the 'Company') (NASDAQ: RXST) and reminds investors of the September 22, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) the Company was experiencing 'adoption challenges' and/or structural issues resulting in declines in sales and utilization; (2) Defendants had overstated the demand for RxSight's products; (3) as a result, RxSight was unlikely to meet its own previously issued financial guidance for fiscal year 2025; and (4) that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis. On July 8, 2025, after the market closed, RxSight reported preliminary second quarter 2025 financial results, revealing significant declines in LDD sales, LAL utilization, and overall revenue. The Company also lowered its full year 2025 guidance by approximately $42.5 million at the midpoint. The Company's Chief Executive Officer, Ronald Kurtz, disclosed that '[a]doption challenges over the last few quarters have been a primary reason for the LDD stall.' On this news, RxSight's stock price fell $4.84, or 37.8%, to close at $7.95 per share on July 9, 2025, on unusually heavy trading volume. The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not. Faruqi & Faruqi, LLP also encourages anyone with information regarding RxSight's conduct to contact the firm, including whistleblowers, former employees, shareholders and others. To learn more about the RxSight class action, go to or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP ( Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
